A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Detention of Ko Wen-je, 3 other defendants ordered to be extended
05/27/2025 11:11 PM - Society
- Culture
Dongyin Township in Matsu Islands joins global Cittaslow network
05/27/2025 09:16 PM - Society
Court rules in Tsai Ing-wen's favor over degree legitimacy case
05/27/2025 09:09 PM - Society
NT$200 million in assets seized from dark web drug suspect detained in U.S.
05/27/2025 08:59 PM